FINDMED (https://findmed.fr), through its series of webinars, introduces you to the expertise and cutting-edge technological platforms of the Carnot Institutes of our consortium, which are accessible to companies in the fields of drugs and health technologies.
During our next webinar on January 15, we propose to focus on the study of the microbiome, the manufacture of innovative galenic forms, and in vivo imaging. Expertise that may be of interest to VSEs, SMEs and ETIs to advance their innovative projects.
This webinar will be led by Hugo Roume, Operational Manager of the SAMBO and METAQUANT platforms of the MetaGenoPolis Institute of INRA and Carnot Qualiment, Maria-Inês Ré, Director of the advanced galenic platform GALA of the Carnot Institute M.I.N.E.S. Albi, and Benoît Haelewyn, Managing Director of the GIP Cyceron du Tremplin Carnot I2C.
The microbiota, mediator of food/physiology
relations SAMBO: biobank of human faecal samples and derived
DNA Creation of proﬁls high-resolution metagenomics of human intestinal samples
Use of New Generation Sequencing (NGS) technology
Manufacture of innovative galenic forms
Handling of active pharmaceutical
ingredients Hot extrusion for improved delivery of active
ingredients Original pharmaceutical forms : Solid
dispersion Production of biomedical
images Adaptation of MRI acquisition sequences according to needs
Technical implementation of experimental
protocols Assistance in image processing and interpretation
Participation in this webinar is free but subject to registration.
Findmed is a consortium of 10 Carnot institutes, which are French academic research institutions dedicated to setting up collaborative research partnerships with the private sector. industry (from SMEs to international corporations). The objective of Findmed is to facilitate the access of private companies to their expertise and technological resources, so as to contribute to the reinforcement of the medication / drug discovery sector in France.